Key facts
activeNX Biotech GmbH
de
R1101_HRB79121
de
active
de
c/o neuraxpharm Arzneimittel GmbH, Elisabeth-Selbert-Straße 23, 40764 Langenfeld.
de
Company dossier
NX Biotech GmbH
RISK SCORE31MEDIUM RISK
Companies at this address
3 totalConnections
8 linksPeople with significant control
9 people| Name | Role | From | Source |
|---|---|---|---|
| Lutz Wengert | Authorized representative | — | Germany registry |
| Olaf Doctor Krampe | Authorized representative | — | Germany registry |
| Stephan Walz | Authorized representative | — | Germany registry |
| Sylvia Doctor Gerke | Authorized representative | — | Germany registry |
| Helmut Jeggle | officer | — | Germany registry |
| Lluis Pérez Cruz | officer | — | Germany registry |
| Ruth Mörkved | officer | — | Germany registry |
| Stephan Walz | officer | — | Germany registry |
| Sylvia Doctor Gerke | officer | — | Germany registry |
Risk signals
2 matchedhigh
Business fragmentation
A director is shared across 26 companies — business-splitting (дробление) pattern
high
Phoenix predecessor
Shares a director with a failed, near-identically-named company (NX Biotech GmbH · dissolved · name-sim 1.0) — phoenixing pattern (shed debts under a new company)
Risk journey — why 31?
2 signals+16
Business fragmentation
+15
Phoenix predecessor
Composite risk score31/100